DEVICE: Alere iCup Dx 14 (00817405020010)
Device Identifier (DI) Information
Alere iCup Dx 14
I-DX-1147-022
In Commercial Distribution
I-DX-1147-022
Instant Technologies, Inc.
I-DX-1147-022
In Commercial Distribution
I-DX-1147-022
Instant Technologies, Inc.
Urine Drug Screen Cup for detection of 14 drugs, Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, Marijuana, Methamphetamine, Methadone, Morphine, Oxycodone, Phencyclidine, Propoxyphene and Tricyclic Antidepressants, CLIA Waived
Device Characteristics
Labeling does not contain MRI Safety Information | |
No | |
No | |
Yes | |
Yes | |
No | |
Yes | |
No | |
No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
---|---|---|---|---|
46994 | Multiple drugs of abuse IVD, kit, rapid ICT, clinical |
A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.
|
Active | false |
FDA Product Code
[?]Product Code | Product Code Name |
---|---|
JXN | Enzyme Immunoassay, Propoxyphene |
LAF | Gas Chromatography, Methamphetamine |
DJR | Enzyme Immunoassay, Methadone |
JXM | Enzyme Immunoassay, Benzodiazepine |
DIS | Enzyme Immunoassay, Barbiturate |
DKZ | Enzyme Immunoassay, Amphetamine |
DIO | Enzyme Immunoassay, Cocaine And Cocaine Metabolites |
LDJ | Enzyme Immunoassay, Cannabinoids |
DJC | Thin Layer Chromatography, Methamphetamine |
DJG | Enzyme Immunoassay, Opiates |
LCM | Enzyme Immunoassay, Phencyclidine |
LFH | U.V. Spectrometry, Tricyclic Antidepressant Drugs |
FDA Premarket Submission
FDA Premarket Submission Number [?] | Supplement Number [?] |
---|---|
K122633 | 000 |
Sterilization
Storage and Handling
[?]Storage and Handling |
---|
Storage Environment Temperature: between 59 and 86 Degrees Fahrenheit |
Clinically Relevant Size
[?]Size Type Text |
---|
No Device Sizes |
Device Record Status
26f79adf-a895-4fd9-a923-af888146d53d
June 10, 2022
8
September 19, 2016
June 10, 2022
8
September 19, 2016
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
---|---|---|---|---|---|
No Package DIs found |
Secondary DI
[?]Issuing Agency [?] | Secondary DI Number |
---|---|
No Secondary DIs found |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
1-800-340-4029
Qa.Portsmouth@abbott.com
Qa.Portsmouth@abbott.com